Kazuhiko Nakayama

Kobe, 6510072, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Corrigendum to "Long-term effects of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease" [Respir Invest, Volume 64, Issue 1, January 2026, 101340].

Corrigendum to "Long-term effects of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease" [Respir Invest, Volume 64, Issue 1, January 2026, 101340].

Journal: Respiratory investigation

Published: January 07, 2026

A Case of IgG4-Related Disease Developing During Long-Term High-Dose Intravenous Epoprostenol Therapy in a Patient With Idiopathic Pulmonary Arterial Hypertension.

A Case of IgG4-Related Disease Developing During Long-Term High-Dose Intravenous Epoprostenol Therapy in a Patient With Idiopathic Pulmonary Arterial Hypertension.

Journal: Pulmonary circulation

Published: October 30, 2025

Long-term effects of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease.

Long-term effects of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease.

Journal: Respiratory investigation

Published: September 04, 2025

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

Journal: ERJ open research

Published: June 06, 2025

Difference in efficacy between pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Difference in efficacy between pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.

Journal: BMC pulmonary medicine

Published: January 16, 2025

Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.

Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.

Journal: Circulation

Published: September 17, 2024

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease.

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease.

Journal: Respiratory investigation

Published: May 24, 2024

JCS 2022 Guideline on Perioperative Cardiovascular Assessment and Management for Non-Cardiac Surgery.

JCS 2022 Guideline on Perioperative Cardiovascular Assessment and Management for Non-Cardiac Surgery.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: August 09, 2023

Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.

Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan Registry.

Journal: JACC. Asia

Published: July 18, 2023

Clinical impact of portal vein pulsatility on the prognosis of hospitalized patients with acute heart failure.

Clinical impact of portal vein pulsatility on the prognosis of hospitalized patients with acute heart failure.

Journal: World journal of cardiology

Published: July 05, 2023

Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.

Combination of echocardiography and pulmonary function tests could predict no complication of pulmonary hypertension during 5 years in patients with systemic sclerosis.

Journal: International journal of rheumatic diseases

Published: November 01, 2022

RC time (resistance × compliance) is related to residual symptom after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

RC time (resistance × compliance) is related to residual symptom after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.

Journal: International journal of cardiology. Heart & vasculature

Published: February 24, 2022

Showing 1-12 of 57

Last Updated: 09/26/2026